Post-IPO Equity - Bluebird Bio - Dec 7, 2016 Funding Round Profile - Cointime

Bitcoin $99,385.62 +0.92%
Ethereum $3,285.22 -2.22%
BNB $622.40 -0.46%
Optimism $2.11 +1.26%
Arbitrum $0.77 -1.33%
Solana $253.82 -0.72%
Polygon $0.48 +6.85%
Cosmos $7.28 +15.12%
Avalanche $39.40 +9.47%

Bitcoin $99,385.62 +0.92%
Ethereum $3,285.22 -2.22%
BNB $622.40 -0.46%
Optimism $2.11 +1.26%
Arbitrum $0.77 -1.33%
Solana $253.82 -0.72%
Polygon $0.48 +6.85%
Cosmos $7.28 +15.12%
Avalanche $39.40 +9.47%

Bluebird Bio

company

Funding Round

Post-IPO Equity

Money Raised

$ 250M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
Jul 25, 2012	Series D	$ 60M	ARCH Venture Partners,ArmaVir Partners,etc.	Detail
Apr 20, 2011	Series C	$ 30M	ARCH Venture Partners,Easton Capital,etc.	Detail
Jun 17, 2004	Series A	$ 8.50M	ABN AMRO Fund,Nazem and Company	Detail
Oct 27, 2012	Series Unknown	$ 9.30M	California Institute for Regenerative Medicine	Detail
Mar 12, 2010	Series B	$ 35M	Easton Capital,Forbion Capital Partners,etc.	Detail
Oct 7, 2004	Series Unknown	$ 12M	ABN AMRO Fund,Easton Capital,etc.	Detail
Mar 16, 2011	Grant	$ 4.20M		Detail